Could a nasal spray help memory loss? A new study using Aptar’s delivery system shows insulin reaching key brain regions, offering new hope for treating Alzheimer’s and mild cognitive impairment.
VIDEO + ARTICLE:
Ergothioneine (ET) from mushrooms has been associated with brain health for years. In a six-year study, seniors consuming 300 grams of mushrooms weekly had 50% less risk of mild cognitive impairment (MCI, often referred to as pre-dementia). Get the facts about this correlation.
A new pineapple turmeric apple cider vinegar blend from Bragg is turning heads—not just for its flavor, but for its potential brain-boosting benefits. Could this tangy tonic play a role in Alzheimer’s prevention?
Salk Institute’s J147 is a derivative of turmeric, a spice used in curry. Learn how it fights memory deficits and has a host of unexpected anti-aging effects in the lab.
A nutrient hidden in your daily meals could hold the key to preventing and slowing Alzheimer’s. Discover what Arizona researchers are revealing about the power of choline.
Rosemary naturally works like Aricept® (generic: donepezil), treating Alzheimer’s by blocking AChE. Learn about rosemary’s dementia-fighting benefits from Dr. J. Duke.
Adopting the MIND diet—even later in life—is linked with reduced dementia risk
DIET: MAGNESIUM appears to do a lot to maintain brain health, prevent cognitive impairment (CI), and fight Alzheimer’s. Learn how.
Copper hits the brain with a one-two punch. It inhibits clearance of, AND it stimulates production of, Alzheimer’s plaque. See why copper is a key player in Alzheimer’s.
With dementia, it’s not just what you eat – it’s also how and where!
Could a nasal spray help memory loss? A new study using Aptar’s delivery system shows insulin reaching key brain regions, offering new hope for treating Alzheimer’s and mild cognitive impairment.
VIDEO + ARTICLE: A promising new oral therapy for Alzheimer’s is now recruiting participants across the USA and Australia, offering fresh hope to families affected by this devastating condition.
Leqembi, the first Alzheimer’s-modifying drug, is a giant step forward—but how many people are getting it, and what does it really cost the average American? We dig into the numbers, the barriers, and the path forward.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
